Get started
AbbVie Inc.

Muted response to launch of $1.75bn partnership with Regenxbio

By patwit9
Following 7% drop after FDA calls for arthritis drug to be labelled with heart-risk warning
Trend Analysis
patwit9

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.